—

Doron Therapeutics Inc.

Phase 3 Estimated

PTP-01

Knee Osteoarthritis

Countdown

297days

Phase 3 readout · ~ Apr 30, 2027 estimated

What's at stake Phase 3 trial results for PTP-01 in Knee Osteoarthritis are due ~ Apr 30, 2027. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · ClinicalTrials.gov verified 15h ago

“CT.gov NCT07219771: Phase 3 trial, sponsor Doron Therapeutics Inc., drug PTP-01. Primary completion date 2027-04 (estimated).”

Add to calendar Post on X Reddit

Provenance